Categories: Regulatory Norms

USFDA approves Unichems generic hypertension tablets



Mumbai Nov 4,2013 : Unichem Laboratories announced the receipt of approval for its generic drug amlodipine besylate tablets by the United States Food and Drug Administration (USFDA). These amlodipine tablets are used in the treatment of hypertension and coronary artery disease. The company announced of having received ANDA approval for amplodipine besylate tablets from the USFDA. The Goa facility of the company would be in charge of commercializing the product.

The tablets amlodipine besylate are antihypertensive drugs, basically calcium channel blockers. These are helpful in reducing blood pressure and are used in treating hypertension. As hypertension is a major risk factor for heart diseases and stroke, it is used in treatment of cardiovascular disorders.

The amlodipine tablets are in the strengths of 2.5mg, 5 mg and 10 mg. These tablets correspond to Norvasc tablets of Pfizer Inc in the same strengths. While there are six to seven companies predominantly dealing with the US market, the company has a huge potential to perform as the current market size is around USD 45-50 million. IGMPI

The Pharma Times News Bureau

Recent Posts

8 Ways Insomnia Affects Skin Health & How To Avoid It

By Dr. Priyanka Kuri, Consultant - Dermatology, Aster Whitefield Hospital, Bengaluru Insomnia, the persistent inability…

1 day ago

Breaking New Ground in Migraine Care: A Landmark Session on Diagnosis and Treatment

Illuminating Latest Advances in Migraine Diagnosis and Treatment New Delhi, December 21, 2024: In a…

1 day ago

Healthcare Startups to Watch Out for in 2025

New Delhi, December 20, 2024: The healthcare sector is undergoing a transformation fueled by technological…

2 days ago

DKMS’s First Global Impact Report of 2023 Serves as New Ray of Hope for Blood Cancer Patients Worldwide

National, December 20, 2024: DKMS just published its first Global Impact Report that outlines the organization's…

2 days ago

Sterling Biotech to start world’s first precision fermentation-based dairy protein factory in Gujarat

Ahmedabad, December 19, 2024: Sterling Biotech Limited, a joint venture between Perfect Day and Zydus, has…

3 days ago

Pioneers in Senior Care, Antara, Partners with Leading Diagnostics Player Dr. Lal PathLabs to Strengthen its Geriatric Care Services

New Delhi, December 19, 2024: Antara Senior Care, an integrated eco-system provider for lifestyle and…

3 days ago